story of the week
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
N. Engl. J. Med 2020 Aug 27;383(9)825-835, LJ Wirth, E Sherman, B Robinson, B Solomon, H Kang, J Lorch, F Worden, M Brose, J Patel, S Leboulleux, Y Godbert, F Barlesi, JC Morris, TK Owonikoko, DSW Tan, O Gautschi, J Weiss, C de la Fouchardière, ME Burkard, J Laskin, MH Taylor, M Kroiss, J Medioni, JW Goldman, TM Bauer, B Levy, VW Zhu, N Lakhani, V Moreno, K Ebata, M Nguyen, D Heirich, EY Zhu, X Huang, L Yang, J Kherani, SM Rothenberg, A Drilon, V Subbiah, MH Shah, ME CabanillasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.